[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100593154":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":17,"centralContacts":31,"locations":37,"responsibleParty":55,"collaborators":17,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":63,"acronym":17,"eligibilityCriteria":64,"healthyVolunteers":65,"sex":66,"minAge":67,"maxAge":68,"enrollmentInfo":69,"targetDuration":17,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":17,"overallStatus":78,"whyStopped":17,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Patel Hospital, Pakistan","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"A","ACTIVE_COMPARATOR","tranexamic acid",[13],"Drug: Tranexamic Acid (TXA)",{"label":15,"type":16,"description":17,"interventionNames":18},"B","PLACEBO_COMPARATOR",null,[19],"Device: Placebo",[21,26],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":17},"DRUG","Tranexamic Acid (TXA)","I would like to see the effect of prophylactic tranexamic acid in women undergoing ELLSCS in preventing PPH in my setup.",[9],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":17},"DEVICE","Placebo","one group will get placebo",[15],[32],{"name":33,"role":34,"phone":35,"phoneExt":17,"email":36},"NIMRA ABID","CONTACT","+92 3342430703","nimrachauhan12@gmail.com",[38],{"facility":39,"status":17,"city":40,"state":41,"zip":17,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Patel Hospital","Karachi","Sindh","Pakistan","PK",{"type":45,"coordinates":46},"Point",[47,48],67.0104,24.8608,{"lat":48,"lon":47},[51],{"name":52,"role":34,"phone":53,"phoneExt":17,"email":54},"patel hospital erc commitee","+92 2138658894","erc@patel-hospital.com",{"type":56,"investigatorFullName":57,"investigatorTitle":58,"investigatorAffiliation":5,"oldNameTitle":17,"oldOrganization":17},"PRINCIPAL_INVESTIGATOR","NIMRA ABID CHAUHAN","RESIDENT OBGYN","100593154","phase-1-role-of-prophylactic-tranexamic-acid-in-prevention-of-post-partum-hemorrhage-in-ellscs-100593154",false,"NCT07002749","ROLE OF PROPHYLACTIC TRANEXAMIC ACID IN PREVENTION OF POST-PARTUM HEMORRHAGE IN ELLSCS","Inclusion Criteria:\n\n* Pregnant women with singleton pregnancy and low risk for PPH admitted for ELLSCS\n\nExclusion Criteria:\n\nWomen with medical disorder or complex pregnancy.\n\n* Women with history of PPH.\n* Women with bleeding disorder.\n* Abnormal placentation (MAP, placenta previa)\n* Multiple pregnancy.",true,"FEMALE","18 Years","45 Years",{"count":70,"type":71},104,"ESTIMATED","INTERVENTIONAL",[74],"PHASE1","IN THIS STUDY WOMEN UNDER GOING ELLSCS WOULD BE DIVIDED INTO TWO GROUPS , ONE GROUP WOULD BE GIVEN TRANEXAMIC ACID WHILE THE OTHER WOULD BE GETTING PLACEBO PROPHYLACTICALLY TO SEE THE EFFECT OF TRANEXAMIC ACID IN PREVENTING PPH.\n\nTHIS IS A RANDOMIZED CONTROLLED TRIAL. THE SAMPLING TECHNIQUE WOULD BE NON-PROBABILITY TECHNIQUE RANDOMIZATION WOULD BE DONE VIA BALLOTING METHOD.",[77],"Post Partum Hemorrhage","NOT_YET_RECRUITING","2025-05-25",{"date":81,"type":82},"2025-06-04","ACTUAL",{"date":84,"type":71},"2025-06-01",{"date":86,"type":71},"2025-12-31",{"name":5,"class":6},1]